Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,648Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Ibrance

PharmaCompass

01

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 4,961

2018 Revenue in Millions : 4,118

Growth (%) : 20

blank

02

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

03

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

04

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 5,120

2021 Revenue in Millions : 5,437

Growth (%) : -6

blank

05

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 4,753

2022 Revenue in Millions : 5,120

Growth (%) : -7

blank

06

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 0

2014 Revenue in Millions : 723

Growth (%) : New Launch

blank

07

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 2,135

2015 Revenue in Millions : 723

Growth (%) : 195

blank

08

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 3,126

2016 Revenue in Millions : 2,136

Growth (%) : 46

blank

09

Brand Name : Ibrance

Palbociclib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Ibrance

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Palbociclib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 4,118

2017 Revenue in Millions : 3,126

Growth (%) : 32%

blank